ATE275945T1 - Oral anzuwendende arzneizubereitung - Google Patents

Oral anzuwendende arzneizubereitung

Info

Publication number
ATE275945T1
ATE275945T1 AT97928275T AT97928275T ATE275945T1 AT E275945 T1 ATE275945 T1 AT E275945T1 AT 97928275 T AT97928275 T AT 97928275T AT 97928275 T AT97928275 T AT 97928275T AT E275945 T1 ATE275945 T1 AT E275945T1
Authority
AT
Austria
Prior art keywords
pct
medicinal preparation
oral medicinal
sec
date
Prior art date
Application number
AT97928275T
Other languages
English (en)
Inventor
Pierre Metziger
Avraham Cohen
Original Assignee
Negma Steba Internat Dev N V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Negma Steba Internat Dev N V filed Critical Negma Steba Internat Dev N V
Application granted granted Critical
Publication of ATE275945T1 publication Critical patent/ATE275945T1/de

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65H—HANDLING THIN OR FILAMENTARY MATERIAL, e.g. SHEETS, WEBS, CABLES
    • B65H23/00—Registering, tensioning, smoothing or guiding webs
    • B65H23/04—Registering, tensioning, smoothing or guiding webs longitudinally
    • B65H23/06—Registering, tensioning, smoothing or guiding webs longitudinally by retarding devices, e.g. acting on web-roll spindle
    • B65H23/10—Registering, tensioning, smoothing or guiding webs longitudinally by retarding devices, e.g. acting on web-roll spindle acting on running web
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B37/00—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding
    • B32B37/14—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding characterised by the properties of the layers
    • B32B37/16—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding characterised by the properties of the layers with all layers existing as coherent layers before laminating
    • B32B37/22—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding characterised by the properties of the layers with all layers existing as coherent layers before laminating involving the assembly of both discrete and continuous layers
    • B32B37/223—One or more of the layers being plastic
    • B32B37/226—Laminating sheets, panels or inserts between two continuous plastic layers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B38/00—Ancillary operations in connection with laminating processes
    • B32B38/18—Handling of layers or the laminate
    • B32B38/1825—Handling of layers or the laminate characterised by the control or constructional features of devices for tensioning, stretching or registration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2309/00—Parameters for the laminating or treatment process; Apparatus details
    • B32B2309/06—Angles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Registering, Tensioning, Guiding Webs, And Rollers Therefor (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT97928275T 1996-07-04 1997-06-30 Oral anzuwendende arzneizubereitung ATE275945T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1003503A NL1003503C2 (nl) 1996-07-04 1996-07-04 Farmaceutische samenstelling voor orale toediening.
PCT/EP1997/003405 WO1998001118A1 (fr) 1996-07-04 1997-06-30 Composition pharmaceutique pour administration par voie orale

Publications (1)

Publication Number Publication Date
ATE275945T1 true ATE275945T1 (de) 2004-10-15

Family

ID=19763138

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97928275T ATE275945T1 (de) 1996-07-04 1997-06-30 Oral anzuwendende arzneizubereitung

Country Status (16)

Country Link
US (1) US5952383A (de)
EP (1) EP0862423B1 (de)
JP (1) JP4209467B2 (de)
KR (1) KR980009519A (de)
CN (1) CN1196477C (de)
AT (1) ATE275945T1 (de)
AU (1) AU3263197A (de)
BR (1) BR9706537A (de)
CA (1) CA2231342C (de)
DE (1) DE69730688T2 (de)
ES (1) ES2230608T3 (de)
IL (1) IL123336A (de)
MX (1) MX9801727A (de)
NL (1) NL1003503C2 (de)
PL (1) PL189358B1 (de)
WO (1) WO1998001118A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999040926A1 (en) * 1998-02-13 1999-08-19 Nutramax Laboratories, Inc. Agents and methods for protection, treatment and repair of connective tissue
US6956048B2 (en) 1999-03-31 2005-10-18 Pharmacia & Upjohn Company Pharmaceutical emulsions for retroviral protease inhibitors
US20020128317A1 (en) * 2001-01-23 2002-09-12 Laboratories Negma Treatment of pathological conditions characterized by an increased IL-1 level
JP5296314B2 (ja) * 2003-07-17 2013-09-25 バナー ファーマキャップス，インコーポレイティド 制御放出製剤
GB0317869D0 (en) * 2003-07-30 2003-09-03 Disperse Ltd Improved drug delivery system
JP5096658B2 (ja) * 2003-10-06 2012-12-12 株式会社三協 生物学的利用能を向上させたソフトカプセル
US7784501B2 (en) 2005-04-08 2010-08-31 Air Products And Chemicals, Inc. Efficient system and method for delivery of product and return of carrier
GB0523041D0 (en) * 2005-11-11 2005-12-21 Cyclacel Ltd Combination
GB0526419D0 (en) * 2005-12-23 2006-02-08 Cyclacel Ltd Formulation
GB0622479D0 (en) * 2006-11-10 2006-12-20 Sosei R & D Ltd Novel salts and their therapeutic use
GB0625283D0 (en) * 2006-12-19 2007-01-24 Cyclacel Ltd Combination
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
CN101371823B (zh) * 2007-03-19 2010-09-15 上海慈瑞医药科技有限公司 二乙酰大黄酸缓释胶囊的制备工艺
CN100475201C (zh) * 2007-03-19 2009-04-08 上海慈瑞医药科技有限公司 二乙酰大黄酸缓释片的制备方法
EP2008651A1 (de) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited Biologisch erodierbares Patch
EP2471516A3 (de) 2007-09-14 2012-12-26 Wockhardt Limited Rhein- oder Diacereinzusammensetzungen
FR2920991A1 (fr) * 2007-09-14 2009-03-20 Wockhardt Ltd Composition a base de diacerheine pour le traitement de l'arthrose
CA2926610A1 (en) 2007-09-27 2009-04-02 Wockhardt Research Centre Pharmaceutical compositions of rhein or diacerein
US20100285114A1 (en) * 2007-09-27 2010-11-11 Rahul Dabre Pharmaceutical compositions of rhein or diacerein
ES2382026T3 (es) 2007-09-27 2012-06-04 Wockhardt Limited Composiciones farmacéuticas autoemulsionantes de reína o diacereína
US20100018107A1 (en) * 2008-07-22 2010-01-28 Christensen Kurt L Method and means for controlling the population of mosquitoes in a non-toxic manner
WO2012075534A1 (en) 2010-12-10 2012-06-14 Ns Technologies Pty Ltd Methods for forming miniemulsions and use thereof for delivering bioactive agents
BR112013023458B1 (pt) 2011-03-14 2020-04-07 Drug Delivery Solutions Ltd composição oftálmica, e, método para fabricar a composição oftálmica
US20140377343A1 (en) 2011-12-23 2014-12-25 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Formulations of flurbiprofen and diacerein
EP3542788A1 (de) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topische zusammensetzung enthaltend calcipotriol und betamethason dipropionat
WO2021024150A1 (en) * 2019-08-03 2021-02-11 Neuheit Pharma Technologies Pvt. Ltd Process for the preparation of anthraquinone topical formulation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA761627B (en) * 1976-03-16 1978-01-25 C Friedmann Improvements in or relating to the treatment of arthritis
US5225192A (en) * 1988-10-17 1993-07-06 Vectorpharma International S.P.A. Poorly soluble medicaments supported on polymer substances in a form suitable for increasing their dissolving rate
IT1189097B (it) * 1986-05-02 1988-01-28 Proter Spa Sali di diacetilreina e loro impiego terapeutico nel trattamento dell'artrosi
IT1197316B (it) * 1986-10-01 1988-11-30 Proter Spa Formulazione galenica ad uso orale di derivati della reina a lento rilascio per impiego terapeutico
IT1230566B (it) * 1988-10-17 1991-10-28 Vectorpharma Int Farmaci poco solubili supportati su sostanze polimeriche in forma atta all'aumento della velocita' di dissoluzione
EP1004318A3 (de) * 1991-06-21 2002-08-07 Takeda Chemical Industries, Ltd. Zyklodextrin-zusammensetzung
IT1256386B (it) * 1992-11-13 1995-12-04 Luigi Boltri Composizioni farmaceutiche comprendenti un farmaco,una sostanza polimerica reticolata,un olio ed un agente tensioattivo
GB9316923D0 (en) * 1993-08-13 1993-09-29 Lilly Industries Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
JP4209467B2 (ja) 2009-01-14
EP0862423A1 (de) 1998-09-09
BR9706537A (pt) 1999-12-28
AU3263197A (en) 1998-02-02
US5952383A (en) 1999-09-14
MX9801727A (es) 1998-11-30
NL1003503C2 (nl) 1998-01-07
WO1998001118A1 (fr) 1998-01-15
DE69730688T2 (de) 2005-09-22
IL123336A (en) 2001-03-19
CA2231342A1 (fr) 1998-01-15
CN1197388A (zh) 1998-10-28
PL325282A1 (en) 1998-07-20
ES2230608T3 (es) 2005-05-01
JPH11512115A (ja) 1999-10-19
CN1196477C (zh) 2005-04-13
PL189358B1 (pl) 2005-07-29
DE69730688D1 (de) 2004-10-21
KR980009519A (ko) 1998-04-30
IL123336A0 (en) 1998-09-24
CA2231342C (fr) 2008-04-08
EP0862423B1 (de) 2004-09-15

Similar Documents

Publication Publication Date Title
DE69730688D1 (de) Oral anzuwendende arzneizubereitung
HU9502624D0 (en) Methods for inhibiting bone loss with 3,4-diarylchroman
IS2034B (is) Ný lyfjablanda til inntöku um munn sem inniheldurnýtt magnesíumsalt ómeprasóls, aðferð við framleiðslu hennar og notkun
HUP9902121A2 (hu) Gonadotropin-leadó hormon antagonista hatású indolszármazékok és ezeket a vegyületeket tartalmazó gyógyszerkészítmények
YU13695A (sh) Upotreba 2-fenil-3-aroilbenzotiofena i njihove farmaceutske formulacije
AR008878A1 (es) Antagonistas del receptor de vitronectina, un metodo para su preparacion, una composicion farmaceutica que los contiene y el uso de las mismas para la preparacion de un medicamento.
BR9908438A (pt) Tabletes de desintegração rápida
MX9700081A (es) Composiciones farmaceuticas de tacrina.
YU2494A (sh) Farmaceutska formulacija za tretiranje zavisnosti od nikotina
NO964486L (no) Anvendelse av visse metanbisfosfonsyrederivater for å forhindre lösning av protese og protesemigrering
ATE213633T1 (de) Lamotrigin haltiges arzneimittel
AR005860A1 (es) Compuestos heterociclicos aromaticos, composiciones farmaceuticas y cosmeticas que los contienen, y su utilización.
ES2062137T3 (es) Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
NO950177D0 (no) Farmakologisk aktive erivater
JO1653B1 (en) The current benzimidazole is a therapeutically active method for preparing it

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties